$51.16
1.66% today
NYSE, Jul 15, 07:50 pm CET
ISIN
US4330001060
Symbol
HIMS

Hims & Hers Health Inc. Stock price

$52.03
-7.75 12.96% 1M
+25.82 98.51% 6M
+27.85 115.18% YTD
+29.19 127.80% 1Y
+46.60 858.20% 3Y
+41.65 401.01% 5Y
+42.23 430.92% 10Y
+42.23 430.92% 20Y
NYSE, Closing price Mon, Jul 14 2025
+4.14 8.64%
ISIN
US4330001060
Symbol
HIMS
Industry

Key metrics

Basic
Market capitalization
$11.6b
Enterprise Value
$11.3b
Net debt
positive
Cash
$322.7m
Shares outstanding
223.6m
Valuation (TTM | estimate)
P/E
78.8 | 76.4
P/S
6.5 | 4.9
EV/Sales
6.4 | 4.7
EV/FCF
47.9
P/B
21.2
Financial Health
Equity Ratio
67.4%
Return on Equity
26.4%
ROCE
18.9%
ROIC
47.0%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$1.8b | $2.4b
EBITDA
$137.9m | $330.4m
EBIT
$115.6m | $193.7m
Net Income
$164.4m | $152.3m
Free Cash Flow
$236.5m
Growth (TTM | estimate)
Revenue
86.0% | 62.3%
EBITDA
2,697.8% | 288.3%
EBIT
2,214.4% | 184.8%
Net Income
7,095.7% | 20.9%
Free Cash Flow
355.7%
Margin (TTM | estimate)
Gross
77.0%
EBITDA
7.7% | 13.8%
EBIT
6.5%
Net
9.2% | 6.4%
Free Cash Flow
13.3%
More
EPS
$0.7
FCF per Share
$1.1
Short interest
34.2%
Employees
1k
Rev per Employee
$1.4m
Show more

Is Hims & Hers Health Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,015 stocks worldwide.

Hims & Hers Health Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

20 Analysts have issued a Hims & Hers Health Inc. forecast:

9x Buy
45%
9x Hold
45%
2x Sell
10%

Analyst Opinions

20 Analysts have issued a Hims & Hers Health Inc. forecast:

Buy
45%
Hold
45%
Sell
10%

Financial data from Hims & Hers Health Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
1,784 1,784
86% 86%
100%
- Direct Costs 410 410
143% 143%
23%
1,375 1,375
74% 74%
77%
- Selling and Administrative Expenses 1,259 1,259
58% 58%
71%
- Research and Development Expense - -
-
-
138 138
2,698% 2,698%
8%
- Depreciation and Amortization 22 22
115% 115%
1%
EBIT (Operating Income) EBIT 116 116
2,214% 2,214%
6%
Net Profit 164 164
7,096% 7,096%
9%

In millions USD.

Don't miss a Thing! We will send you all news about Hims & Hers Health Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Hims & Hers Health Inc. Stock News

Neutral
GlobeNewsWire
about 2 hours ago
LOS ANGELES, July 15, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming August 25, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Hims & Hers Health, Inc. (“Hims” or the “Company”) (NYSE: HIMS) securities between April 29, 2025 and June 23, 2025, inclusive (the “Class Period”).
Neutral
PRNewsWire
about 3 hours ago
LOS ANGELES , July 15, 2025 /PRNewswire/ -- The DJS Law Group announces that it is investigating claims on behalf of investors of Hims & Hers Health, Inc. ("Hims & Hers" or "the Company") (NYSE: HIMS) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses on whether the Company issued misleading statements and/or failed to disclose information pertinent to inves...
Neutral
Business Wire
about 22 hours ago
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced that it will report second quarter 2025 financial results after the market closes on Monday, August 4, 2025. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day. The conference call can be accessed by dialing...
More Hims & Hers Health Inc. News

Company Profile

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Head office United States
CEO Andrew Dudum
Employees 1,046
Founded 2017
Website www.forhims.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today